These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1679342)

  • 1. Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
    McConkey B
    Curr Opin Rheumatol; 1991 Jun; 3(3):348-54. PubMed ID: 1679342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine.
    Conaghan PG; Brooks P
    Curr Opin Rheumatol; 1995 May; 7(3):167-73. PubMed ID: 7612407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-modifying antirheumatic drugs.
    Conaghan PG; Lehmann T; Brooks P
    Curr Opin Rheumatol; 1997 May; 9(3):183-90. PubMed ID: 9204252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1991 Jul; 33(848):65-70. PubMed ID: 1676134
    [No Abstract]   [Full Text] [Related]  

  • 5. Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
    Smith MD
    Curr Opin Rheumatol; 1990 Jun; 2(3):489-96. PubMed ID: 1975503
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis.
    Paulus HE
    Arthritis Rheum; 1990 Jan; 33(1):113-20. PubMed ID: 1967942
    [No Abstract]   [Full Text] [Related]  

  • 7. Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine.
    Conaghan PG; Brooks P
    Curr Opin Rheumatol; 1996 May; 8(3):176-82. PubMed ID: 8796975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamine.
    Girgis L; Conaghan PG; Brooks P
    Curr Opin Rheumatol; 1994 May; 6(3):252-61. PubMed ID: 7914739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-modifying antirheumatic drugs. Potential effects in older patients.
    Gardner G; Furst DE
    Drugs Aging; 1995 Dec; 7(6):420-37. PubMed ID: 8601050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and D-penicillamine.
    Conaghan PG; Brooks P
    Curr Opin Rheumatol; 1993 May; 5(3):276-81. PubMed ID: 8099805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-modifying antirheumatic drugs.
    Li E; Brooks P; Conaghan PG
    Curr Opin Rheumatol; 1998 May; 10(3):159-68. PubMed ID: 9608316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS
    Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs.
    Case JP
    Am J Ther; 2001; 8(2):123-43. PubMed ID: 11304666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A disease activity index: its use in clinical trials and disease assessment in patients with rheumatoid arthritis.
    Davis MJ; Dawes PT
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):50-6. PubMed ID: 7904086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
    Smith MD
    Curr Opin Rheumatol; 1989 Jun; 1(1):74-9. PubMed ID: 2577111
    [No Abstract]   [Full Text] [Related]  

  • 16. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
    Aletaha D; Smolen JS
    Rheumatology (Oxford); 2002 Dec; 41(12):1367-74. PubMed ID: 12468815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH; Whelton A
    Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Care of the person with rheumatoid arthritis.
    Sienknecht CW
    Compr Ther; 1990 Apr; 16(4):29-35. PubMed ID: 1970764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
    O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
    N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.